141 related articles for article (PubMed ID: 16775424)
21. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
Richard S
Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
[No Abstract] [Full Text] [Related]
22. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
Wiesener MS; Eckardt KU
Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075
[No Abstract] [Full Text] [Related]
23. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
Decker HJ; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
[TBL] [Abstract][Full Text] [Related]
24. Genetics of renal cell carcinoma.
Daniel LN; Linehan WM
Semin Urol; 1989 Nov; 7(4):258-63. PubMed ID: 2575784
[No Abstract] [Full Text] [Related]
25. Renal cancer genetics: von Hippel Lindau and other syndromes.
Fleming S
Int J Dev Biol; 1999; 43(5):469-71. PubMed ID: 10535326
[TBL] [Abstract][Full Text] [Related]
26. von Hippel-Lindau syndrome: a rare syndrome as the clue for the molecular basis of common renal disorders.
Neumann HP
Nephrol Dial Transplant; 1995; 10(9):1498-9. PubMed ID: 8559448
[No Abstract] [Full Text] [Related]
27. Genetic basis of renal cell cancer.
Linehan WM; Gnarra JR; Lerman MI; Latif F; Zbar B
Important Adv Oncol; 1993; ():47-70. PubMed ID: 8505056
[No Abstract] [Full Text] [Related]
28. von Hippel-Lindau disease.
Connor JM
Q J Med; 1990 Nov; 77(283):1099-100. PubMed ID: 2274655
[No Abstract] [Full Text] [Related]
29. Genetic mechanisms in von Hippel-Lindau disease.
Lancet; 1991 Jun; 337(8755):1477-9. PubMed ID: 1675341
[No Abstract] [Full Text] [Related]
30. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
31. Von Hippel-Lindau disease: the role of gene analysis in affected families.
Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
[No Abstract] [Full Text] [Related]
32. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
Friedrich CA
Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110
[TBL] [Abstract][Full Text] [Related]
34. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of kidney cancer.
Zimmer M; Iliopoulos O
Cancer Treat Res; 2003; 116():3-27. PubMed ID: 14650823
[No Abstract] [Full Text] [Related]
36. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
Meister M; Choyke P; Anderson C; Patel U
Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
[TBL] [Abstract][Full Text] [Related]
38. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
39. Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Linehan WM; Vasselli J; Srinivasan R; Walther MM; Merino M; Choyke P; Vocke C; Schmidt L; Isaacs JS; Glenn G; Toro J; Zbar B; Bottaro D; Neckers L
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018
[TBL] [Abstract][Full Text] [Related]
40. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
